|
GHS works both on a retainer basis and a project basis for its clients.
Since our work usually involves high level corporate strategy and new market entry, our examples are described with limited detail. However, we believe that they are illustrative of GHS’s focus and activities.
:: Strategic Guidance
For a Fortune 500 company: On-going strategic input, review, and guidance for senior executives around the company’s utilization of the new science of molecular medicine to reduce health care costs for their covered populations.
:: Executive Briefings and Discussions
For several Fortune 500 companies: Executive briefings and strategy discussions to introduce personalized health and wellness markets to them and allow them to begin to consider options for entering these markets.
:: Business Planning
For a venture-backed U.S. diagnostics company: Business strategy development around market entry, review and selection of their most commercially viable offerings, quick paths to revenues, and development of their business plan.
:: Strategy Review
For a venture capital firm: Review of their internal plan for investing their new fund focused on diagnostics.
:: Due Diligence
For a Fortune 500 company: In-depth scientific, competitive, commercial, and market due diligence around a major initiative with a potential partner.
:: Market Introduction
For a European diagnostic firm: Strategy development, offering diagnostic and disease category selection and detailed operational planning for entry into U.S. markets. Specific issues dealt with included regulatory pathways, sales and marketing, payer strategies, reimbursement, interaction with patient advocacy groups, and communications.
:: Market Expansion
For a major spa: Consultation on expanding their market scope through branded consumer wellness products.
|
